Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy; Bridging Study for Korea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2012 New trial record